Cite
IL-34 reprograms glycolytic and osteoclastic RA macrophages via Syndecan-1 and M-CSFR
MLA
Van Raemdonck, Katrien, et al. IL-34 Reprograms Glycolytic and Osteoclastic RA Macrophages via Syndecan-1 and M-CSFR. Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8cc24996e283e1d33f3dc5b215d760be&authtype=sso&custid=ns315887.
APA
Van Raemdonck, K., Umar, S., Palasiewicz, K., Volin, M. V., Elshabrawy, H. A., Romay, B., Tetali, C., Ahmed, A., Amin, M. A., Zomorrodi, R. K., Sweiss, N., & Shahrara, S. (2021). IL-34 reprograms glycolytic and osteoclastic RA macrophages via Syndecan-1 and M-CSFR.
Chicago
Van Raemdonck, Katrien, Sadiq Umar, Karol Palasiewicz, Michael V. Volin, Hatem A. Elshabrawy, Bianca Romay, Chandana Tetali, et al. 2021. “IL-34 Reprograms Glycolytic and Osteoclastic RA Macrophages via Syndecan-1 and M-CSFR,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8cc24996e283e1d33f3dc5b215d760be&authtype=sso&custid=ns315887.